According to a new report, published by KBV research, The Global Kyphoplasty Market size is expected to reach $837.1 million by 2028, rising at a market growth of 6.2% CAGR during the forecast period.
The Kyphoplasty Systems segment has shown the growth rate of 5.7% during (2022 - 2028). This is because of the numerous developments and launches of products like balloon inflation devices as well as bone access devices. As the kyphoplasty is considered to be minimally invasive it can reduce blood loss due to which the market for kyphoplasty is expected to expand. In addition, the operation is simple, and fast.
The Osteoporosis segment is leading the Global Kyphoplasty Market by Indication in 2021, thereby, achieving a market value of $680.1 million by 2028. As a result of an increase in the world's geriatric population and an increase in osteoporosis cases the demand for kyphoplasty is rising gradually. Due to the rise in traffic accidents, sports injuries, and cancer cases among the population, this segment would fuel the kyphoplasty market.
The Ambulatory Surgical Centers segment is showcasing CAGR of 8.2% during (2022 - 2028). The rise in osteoporosis diagnoses and the need for ASCs due to their specialized care and welcoming environments for senior patients is increasing the demand for kyphoplasty in ASCs. A convenient alternative to hospitals that provides the same level of treatment at a cheaper cost to patients is an ambulatory surgery facility.
The North America market dominated the Global Kyphoplasty Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $314.2 million by 2028. The Europe market is exhibiting a CAGR of 5.8% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 5.8% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/kyphoplasty-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Stryker Corporation, MicroPort Scientific Corporation, IZI Medical Products, LLC (Landauer, Inc.), Merit Medical Systems, Inc., Jiangsu Changmei Medtech Co. Ltd., G21 S.r.l., Seawon Meditech Co., Ltd., joimax® GmbH and Taeyeon medical Co., Ltd.
By Product Type
By Indication
By End User
By Geography
Companies Profiled
Unique Offerings 
